hyperthyroidism and glp 1 Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality TSH Levels Glucagon-like peptide 1 receptor agonist

Insurance Barriers: May not cover for weight loss (only approved for diabetes) Requires type 2 diabetes diagnosis for coverage Extensive prior authorization requirements May require trying other medications first High copays even with coverage Supply Shortages: Both Mounjaro and Zepbound have experienced periodic shortages since launch, making consistent access difficult

This makes post-weight-loss assessment particularly relevant in this age group Ready to Explore Cosmetic Options

Phase 3 data report ~16.6% mean weight loss with adherence, with outcomes comparable to injectable Wegovy 2.4 mg

Melzer C, von der Ohe J, Otterbein H, Ungefroren H, Hass R

Exendin-4 treatment following DSS-induced colitis does not prevent weight loss, colon length shortening, or improve colon damage score, however, reductions in colon weight are attributable to a reduction of edema (Yusta et al., 2015)

Epub 2021 Oct 27